CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Derivatives Options or other derivatives
- 4 Grant or award COO and CFO acquired 79,113 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CEO acquired 20,000 shares (option exercise)
- 4 Exercise or conversion COO and CFO acquired 7,500 shares (option exercise)
- 4/A Open-market buy Director bought 50,000 shares at $1.56 ($78,185)
- 4 Open-market buy Director bought 50,000 shares at $1.56 ($78,185)
- 4 Open-market buy CEO and Director bought 20,000 shares at $1.55 ($31,000)
- 4 Open-market buy Director bought 50,000 shares at an average $1.42 ($71,228)
- 4 Open-market sale 10% owner sold 1,300,000 shares at $1.40 ($1,820,000)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 24 · 475 filings